Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-18
2009-02-03
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S360500
Reexamination Certificate
active
07485661
ABSTRACT:
Bicyclo-pyrazoles of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
REFERENCES:
patent: 2006/0122249 (2006-06-01), Tonani et al.
Bindi Simona
D'Anello Matteo
Fancelli Daniele
Pittala′ Valeria
Tonani Roberto
Pfizer Italia S.r.l.
Saeed Kamal A
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Heterobicyclic pyrazole derivatives as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterobicyclic pyrazole derivatives as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobicyclic pyrazole derivatives as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4056265